Netherlands - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Netherlands Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry fell by 1.8% year on year. With $289,193,594.01 Million PPP in 2019, the country was number 20 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Netherlands is overtaken by Slovenia, which was number 19 at $343,555,237.12 Million PPP and is followed by Israel with $287,878,980.84 Million PPP. United States lead the ranking with $70,565,318,932.39 Million PPP in 2019, +3.3% compared to 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 289,193,594.01 |
| 2018 | 299,372,083.32 |
| 2017 | 321,136,288.09 |
| 2016 | 296,179,402.86 |
| 2015 | 318,577,992.09 |
How does Netherlands rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 19 |
#19
Slovenia
|
343,555,237.12 | 2019 | +3.1 % | +4.5 % | View data | |
| 20 |
#20
Netherlands
|
289,193,594.01 | 2019 | -3.4 % | -1.8 % | View data | |
| 21 |
#21
Israel
|
287,878,980.84 | 2019 | -0.9 % | +0.6 % | View data | |